IRIS
GALIERO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 255
NA - Nord America 227
AS - Asia 70
OC - Oceania 1
Totale 553
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 225
IE - Irlanda 127
IT - Italia 85
SG - Singapore 34
CN - Cina 13
DE - Germania 12
KR - Corea 11
CZ - Repubblica Ceca 6
FI - Finlandia 6
GB - Regno Unito 6
CH - Svizzera 3
FR - Francia 3
IR - Iran 3
TR - Turchia 3
ID - Indonesia 2
IN - India 2
MO - Macao, regione amministrativa speciale della Cina 2
RS - Serbia 2
AU - Australia 1
BE - Belgio 1
CA - Canada 1
LT - Lituania 1
MX - Messico 1
NL - Olanda 1
RO - Romania 1
SE - Svezia 1
Totale 553
Salva come PNG Salva come JPEG
Città #
Dublin 119
New York 44
Chandler 32
Naples 26
Singapore 19
San Francisco 12
Seoul 11
Beijing 8
Cambridge 7
Liveri 7
Boardman 6
Brno 6
Milan 6
Princeton 6
Roxbury 6
Munich 5
Ashburn 4
Atlanta 4
Florence 4
Boydton 3
Bremen 3
Helsinki 3
Istanbul 3
Lappeenranta 3
Paris 3
Zurich 3
Avellino 2
Banda Aceh 2
Belgrade 2
Camden 2
Crispano 2
Hanover 2
Macao 2
Monza 2
Piano di Sorrento 2
Rimini 2
San Felice A Cancello 2
Aci Sant'Antonio 1
Amsterdam 1
Antea 1
Brussels 1
Carinaro 1
Castellammare di Stabia 1
Dehradun 1
Eboli 1
Fisciano 1
Heroica Matamoros 1
Houston 1
Kolkata 1
Laurel 1
Mondragone 1
Montreal 1
Portici 1
Portico di Caserta 1
Rome 1
San Mateo 1
Shenzhen 1
Suceava 1
Totale 396
Salva come PNG Salva come JPEG
Nome #
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 47
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 42
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 40
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 34
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 34
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 32
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 31
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 28
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 27
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 24
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 22
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 21
Polypharmacy and major adverse events in atrial fibrillation 18
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management 16
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 16
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 14
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 13
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 13
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 12
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 12
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 12
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 12
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 11
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 10
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 8
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 8
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 8
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 6
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 5
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 4
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 3
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study 3
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 3
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 3
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 2
Totale 594
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202246 0 0 0 0 0 0 0 0 9 10 8 19
2022/2023225 9 9 4 7 33 11 5 7 110 10 9 11
2023/2024304 24 14 9 26 53 47 20 9 8 23 37 34
2024/202519 5 14 0 0 0 0 0 0 0 0 0 0
Totale 594